Brodsky, R. A., Peffault de Latour, R., Rottinghaus, S. T., Röth, A., Risitano, A. M., Weitz, I. C., Hillmen, P., Maciejewski, J. P., Szer, J., Lee, J. W., Kulasekararaj, A. G., Volles, L., Damokosh, A. I., Ortiz, S., Shafner, L., Liu, P., Hill, A. and Schrezenmeier, H. (2020) “Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria”, Haematologica. Pavia, Italy, 106(1), pp. 230-237. doi: 10.3324/haematol.2019.236877.